A survey of incidence rate of taste disorder in cancer patients receiving chemotherapy

A survey of incidence rate of taste disorder in cancer patients receiving chemotherapy - Relationship between chemotherapy and taste disorder

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007879

Enrollment

Registered

2012-06-20

Start date

2012-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast / Colon / Lung cancer

Interventions

Measurement of threshold of saltiness by test paper (SALSAVE)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Histologically or cytologically confirmed lung cancer, histologically proven breast and colon cancer 2) Age: 20 and over 3) Chemo-naive patient 4) ECOG performance status 2 or less 5) Life expectancy more than 3 months 6) Written informed consent

Exclusion criteria

Exclusion criteria: 1) Undiagnosed disease 2) Patients incapable of taking chemotherapy 3) Severe comorbidities 4) Patient taking zinc preparation 5) Other conditions inadequate for this study

Design outcomes

Primary

Measure	Time frame
Incidence rate and timing of taste disorder in cancer patients who underwent chemotherapy	—

Countries

Japan

Contacts

Public ContactHiroshi Yokouchi

Fukushima Medical University, School of Medicine Department of Pulmonary Medicine

hyokouch@gmail.com024-547-1360

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026